BioPharmX Corp Business Finance Contracts & Agreements
94 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (1)
- Exchange Agreements (2)
- Investor Rights Agreements (2)
- Loan Agreements (3)
- Note Agreements (6)
- Purchase Agreements (10)
- Registration Rights Agreements (5)
- Security Agreements (3)
- Stock Agreements (9)
- Subscription Agreements (5)
- Underwriting Agreements (8)
- Waiver Agreements (1)
- Warrant Agreements (38)
- Form of DIP Credit Agreement, to be entered intoby the Company, Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO USHolding, Inc (Filed With SEC on November 17, 2023)
- First Amendment to Secured Bridge Loan Agreement, dated October 27, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US... (Filed With SEC on October 30, 2023)
- Form of Warrant Amendment (Filed With SEC on August 31, 2023)
- Secured Bridge Loan Agreement, dated August 30, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US Holding, Inc (Filed With SEC on August 31, 2023)
- Form of Securities Purchase Agreement, dated October 3, 2022, by and among Timber Pharmaceuticals, Inc. and the purchaser signatories thereto (Filed With SEC on October 3, 2022)
- Form of Series 2 Warrant (Filed With SEC on October 3, 2022)
- Form of Series 1 Warrant (Filed With SEC on October 3, 2022)
- Form of Common Warrant (Filed With SEC on August 8, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 8, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on August 2, 2022)
- Form of Common Warrant (Filed With SEC on August 2, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 2, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 2, 2022)
- Form of Warrant (Filed With SEC on November 4, 2021)
- Form of Pre-funded Warrant (Filed With SEC on November 4, 2021)
- Underwriting Agreement, dated November 2, 2021 by and between Timber Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 4, 2021)
- Form of Restricted Stock Award Agreement (Filed With SEC on March 23, 2021)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 23, 2021)
- Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on March 23, 2021)
- Description of Capital Stock (Filed With SEC on March 23, 2021)
- Form of Waiver Agreement, dated as of November 19, 2020, by and between Timber Pharmaceuticals, Inc. and the Holders (Filed With SEC on November 20, 2020)
- Amended and Restated Registration Rights Agreement, dated July 17, 2020, by and between Timber Pharmaceuticals, Inc. and certain buyers named therein (Filed With SEC on August 18, 2020)
- Form of B Warrant (Filed With SEC on June 3, 2020)
- Form of A Warrant (Filed With SEC on June 3, 2020)
- Form of Amendment No. 1 to Securities Purchase Agreement, dated April 27, 2020, by and among Timber, BioPharmX and certain investors parties thereto (Filed With SEC on April 27, 2020)
- Description of Capital Stock (Filed With SEC on March 23, 2020)
- Form of Exchange Agreement, dated January 28, 2020, between BioPharmX and the Holders (Filed With SEC on January 29, 2020)
- Note, dated January 28, 2020, made by BioPharmX in favor of Timber (Filed With SEC on January 29, 2020)
- Bridge Loan Credit Agreement, dated January 28, 2020, between BioPharmX and Timber (Filed With SEC on January 29, 2020)
- Bridge Warrant To Purchase Common Stock, dated January 28, 2020, made by BioPharmX in favor of Timber (Filed With SEC on January 29, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on March 21, 2019)
- Form of Warrant (Filed With SEC on December 7, 2018)
- Form of Warrant Exercise Agreement (Filed With SEC on November 21, 2018)
- Form of New Warrant (Filed With SEC on November 21, 2018)
- Form of Representatives Warrant (Filed With SEC on November 27, 2017)
- Form of Series B Common Warrant (Filed With SEC on November 27, 2017)
- Form of Series A Common Warrant (Filed With SEC on November 27, 2017)
- Form of Pre-funded Warrant (Filed With SEC on November 27, 2017)
- Form of Series B Common Warrant (Filed With SEC on November 20, 2017)
- Form of Series B Common Warrant (Filed With SEC on November 17, 2017)
